Lead Generation - EME Access Message | Access control messages | Drug Target Review

Skip to main content
Skip to navigation

Topics

Neurological disorders

Related articles

News
Automated MRI pipeline standardises preclinical stroke damage measurement

2026-08-14T11:20:00Z

Drug Target Review
News
Meis2 gene identified as potential therapeutic target for neurodevelopmental disorders

2026-08-13T11:07:00Z

Drug Target Review
News
Nanomedicine for glioblastoma: overcoming the blood-brain barrier

2026-08-13T10:32:00Z

Drug Target Review
News
VY1706 Alzheimer’s gene therapy achieves 75 percent tau reduction in preclinical study

2026-08-05T09:35:00Z

Drug Target Review
News
Glymphatic gene therapy platform targets brain’s glial cells precisely

2026-08-04T12:42:00Z

Drug Target Review
Article
Why the blood–brain barrier blocks most drugs – and how ultrasound could help

2026-07-31T06:00:00Z

Contributor Dr Davinder Ramsingh, Drug Target Review

Partner content

Article
Women in STEM: resilience and leadership in rare disease research

2026-05-19T09:46:00

Contributor Dr Nitza Thomasson
Webinar
What it takes to automate high-content imaging at scale

2026-03-25T15:00:00

Sponsored by Yokogawa
Webinar
The truth about AI in drug discovery: what the experts really think

2026-03-11T14:00:00

Sponsored by Merck
Article
Why the blood–brain barrier blocks most drugs – and how ultrasound could help

2026-07-31T06:00:00

Contributor Dr Davinder Ramsingh, Drug Target Review
Article
How AI and human biology data led to a new addiction drug candidate

2026-07-21T09:36:00

Contributor Jayson Uffens, Drug Target Review
Webinar
Oligonucleotide therapeutics safety considerations across drug development

2026-10-07T14:00:00

Sponsored by WuXi AppTec